Rankings
▼
Calendar
DSGN Q4 2024 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DSGN
Design Therapeutics, Inc.
$569M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$17M
Net Income
-$14M
EPS (Diluted)
$-0.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$252M
Total Liabilities
$10M
Stockholders' Equity
$242M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$17M
-$15M
-10.4%
Net Income
-$14M
-$12M
-15.3%
← FY 2024
All Quarters
Q1 2025 →